Theravectys secures exclusive access to a synthetic humanized nanobody library from Institut Curie and strengthens its proprietary immunotherapeutic platform

14 avril 2015 : Theravectys secures exclusive access to a synthetic humanized nanobody library from Institut Curie and strengthens its proprietary immunotherapeutic platform. Cliquez ici pour lire le communiqué de presse